We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$14.7B
AUM Growth
-$2.91B
Cap. Flow
-$2.63B
Cap. Flow %
-17.88%
Top 10 Hldgs %
6.52%
Holding
4,319
New
695
Increased
988
Reduced
1,077
Closed
1,450

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$66.2M
2
WFC icon
Wells Fargo
WFC
+$57M
3
SNOW icon
Snowflake
SNOW
+$53.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$52.1M
5
AVGO icon
Broadcom
AVGO
+$43.5M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$76.6M
2
ZTS icon
Zoetis
ZTS
+$67.5M
3
UBER icon
Uber
UBER
+$57.3M
4
MMM icon
3M
MMM
+$53.2M
5
NFLX icon
Netflix
NFLX
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Industrials 6.11%
3 Consumer Discretionary 5.41%
4 Financials 4.9%
5 Healthcare 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCG icon
3076
Cheche Group
CCG
$33M
-337
Closed -$43.5K
CCI icon
3077
Crown Castle
CCI
$31.6B
-10,971
Closed -$1.16M
CCK icon
3078
Crown Holdings
CCK
$13.2B
-76,665
Closed -$6.18M
CCU icon
3079
Compañía de Cervecerías Unidas
CCU
$2.26B
-49,639
Closed -$595K
CDLR icon
3080
Cadeler
CDLR
$2.26B
-18,635
Closed -$338K
CDLX icon
3081
Cardlytics
CDLX
$21.8M
-20,671
Closed -$3M
CDNA icon
3082
CareDx
CDNA
$2.43B
-273,849
Closed -$2.9M
CDRE icon
3083
Cadre Holdings
CDRE
$1.41B
-2,102
Closed -$76.1K
CDTX
3084
DELISTED
Cidara Therapeutics
CDTX
-15
Closed -$267
CE icon
3085
CALL
Celanese
CE
$5.04B
-1,400
Closed -$241K
CECO icon
3086
Ceco Environmental
CECO
$4.15B
-44,763
Closed -$1.03M
CELC icon
3087
Celcuity
CELC
$4.48B
-11,582
Closed -$250K
CELH icon
3088
Celsius Holdings
CELH
$6.77B
-441,845
Closed -$33.4M
CF icon
3089
CALL
CF Industries
CF
$18.2B
-22,400
Closed -$1.86M
CFFN icon
3090
Capitol Federal Financial
CFFN
$1.1B
-28,946
Closed -$173K
CFG icon
3091
PUT
Citizens Financial Group
CFG
$30.8B
-7,100
Closed -$258K
CFLT
3092
DELISTED
Confluent
CFLT
-400,271
Closed -$11.5M
CGBD icon
3093
Carlyle Secured Lending
CGBD
$766M
-15,666
Closed -$255K
CGEM icon
3094
Cullinan Oncology
CGEM
$1.2B
-55,888
Closed -$952K
CGEN icon
3095
Compugen
CGEN
$224M
-30,748
Closed -$79.3K
CGNT icon
3096
Cognyte Software
CGNT
$690M
-28,836
Closed -$238K
CGNX icon
3097
CALL
Cognex
CGNX
$10.9B
-16,600
Closed -$704K
CGNX icon
3098
PUT
Cognex
CGNX
$10.9B
-9,400
Closed -$399K
CGON icon
3099
CG Oncology
CGON
$6.82B
-28,672
Closed -$1.26M
CHD icon
3100
CALL
Church & Dwight Co
CHD
$24.4B
-6,900
Closed -$720K

Similar funds

Cubist Systematic Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, Cubist Systematic Strategies held 4,319 positions worth $14.7B, down 17% from $17.6B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Cubist Systematic Strategies withdrew a net $2.63B in Q2 2024, closing 1,450 positions and reducing 1,077 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $76.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in General Motors worth $68.2M.

  • Cubist Systematic Strategies's largest Q2 2024 buy was General Motors: 1,467,209 shares worth $68.2M.
  • Cubist Systematic Strategies added most to Thermo Fisher Scientific in Q2 2024, an estimated $52.1M increase.
  • Cubist Systematic Strategies's biggest Q2 2024 reduction was Uber, cutting an estimated $57.3M.
  • Cubist Systematic Strategies fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $76.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.5% of its $14.7B portfolio in Q2 2024.
  • Cubist Systematic Strategies opened 695 new positions and closed 1,450 in Q2 2024.
  • Cubist Systematic Strategies's portfolio value fell 17% quarter-over-quarter to $14.7B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.